PTCT PTC Therapeutics
- 25.490
- +0.280+1.11%
PTC Therapeutics News
PTC Therapeutics | 10-Q: Quarterly report
PTC Therapeutics | 8-K: PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Klein Matthew B.
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pauwels Eric
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Klein Matthew B.
PTC Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
PTC Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
PTC Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Golden Lee Scott
PTC Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
PTC Therapeutics | 8-K: PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
PTC Therapeutics | 10-K: Annual report
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Almstead Neil Gregory
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Utter Christine Marie
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pauwels Eric
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SCHMERTZLER MICHAEL
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Okey Stephanie
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SOUTHWELL DAVID P
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bell William F. Jr.
PTC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Smith Mary L.
Analysis
Price Target
No Data
